FibroBiologics, Inc. Common Stock (FBLG) — Net Asset Quality Index
FibroBiologics, Inc. Common Stock (FBLG) has a Net Asset Quality Index of 1.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $8.74 Million minus total liabilities of $8.62 Million yields net assets of $125.00K. A higher index indicates a stronger, lower-leverage balance sheet. Also explore FBLG asset base for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
FibroBiologics, Inc. Common Stock Net Asset Quality Index Over Time (2022–2025)
This chart shows how FibroBiologics, Inc. Common Stock's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the index stands at 1.4%, representing net assets of $125.00K against total assets of $8.74 Million USD. See working capital to net assets of FibroBiologics, Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for FibroBiologics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for FibroBiologics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see FibroBiologics, Inc. Common Stock (FBLG) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 16.6% | $2.73 Million | $16.45 Million | $13.71 Million | ▲ +6.0 pp |
| 2024 | 10.6% | $1.25 Million | $11.82 Million | $10.57 Million | ▲ +93.4 pp |
| 2023 | -82.8% | $-4.00 Million | $4.82 Million | $8.82 Million | ▲ +192.8 pp |
| 2022 | -275.6% | $-1.29 Million | $468.00K | $1.76 Million | — |